March 03, 2015 5:42 PM ET


Company Overview of ViroPharma Inc.

Executive Profile

Claude H. Nash Ph.D.

Executive Chairman, SelectX Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships


Dr. Claude H. Nash Ph.D. served as the Chief Executive Officer of Accera, Inc. Dr. Nash served as the Chief Executive Officer of ViroPharma Inc. and President from 1994 to 2002. Dr. Nash has more than 30 years of pharmaceutical industry experience, which includes advancing more than 20 compounds into clinical trials, five of which are approved products. Dr. Nash co-founded ViroPharma Inc., and served as its Executive Officer until August 2004. He served as the Chief ...

Corporate Headquarters

730 Stockton Drive
Exton, Pennsylvania 19341

United States

Phone: 610-458-7300
Fax: 610-458-7380

Board Members Memberships

Executive Chairman
Chairman of the Board
Former Executive Officer
Director and Chairman of Compensation Committee
Former Director


Colorado State University
Colorado State University
Lamar University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ViroPharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at